<DOC>
	<DOCNO>NCT01583517</DOCNO>
	<brief_summary>The therapeutic impact ERCP sphincterotomy management patient idiopathic recurrent acute pancreatitis ( RAP ) need study . The investigator conduct single center , feasibility , randomize trial determine 1 ) role pancreatic manometry predict future episode RAP 2 ) difference efficacy , biliary ( BES ) pancreatobiliary ( dual ) endoscopic sphincterotomy ( DES ) .</brief_summary>
	<brief_title>ERCP Idiopathic Recurrent Acute Pancreatitis</brief_title>
	<detailed_description>Patients idiopathic RAP , define ≥2 unexplained ( per treat physician ) episodes acute pancreatitis ( base standard criterion ) require hospitalization , prospectively enrol . All patient undergo ERCP manometry , stratify randomization base assessment pancreatic basal sphincter pressure . If &lt; 40mmHg , patient randomize sham biliary sphincterotomy ( BES ) . If ≥40mmHg , patient randomize BES pancreatobiliary ( `` dual '' ) sphincterotomy ( DES ) . Patients physician blind assignment group . Patients follow 10 year determine 1 ) incidence RAP require hospitalization ( use standard definition ) 2 ) interval development chronic pancreatitis ( CP ) . Differences patient develop RAP follow-up compare evaluate factor associate AP follow-up .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<criteria>Idiopathic recurrent acute pancreatitis , define two episode require hospitalization ERCP SOM plan Chronic pancreatitis Pancreas divisum Alternate etiology identify ( e.g. , CBD stone , IPMN ) Inability perform pancreatic manometry Pregnancy , age &lt; 18 , incarceration Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Acute pancreatitis</keyword>
	<keyword>ERCP</keyword>
	<keyword>Sphincterotomy</keyword>
	<keyword>Manometry</keyword>
	<keyword>Sphincter Oddi dysfunction</keyword>
</DOC>